title: Mitochondrial localized Stat3 promotes breast cancer growth via phosphorylation of serine 727.
abstract: Signal transducer and activator of transcription 3 (Stat3) is a key mediator in the development of many cancers. For 20 years, it has been assumed that Stat3 mediates its biological activities as a nuclear localized transcription factor activated by many cytokines. However, recent studies from this laboratory and others indicate that Stat3 has an independent function in the mitochondria (mitoStat3) where it controls the activity of the electron transport chain (ETC) and mediates Ras-induced transformation of mouse embryo fibroblasts. The actions of mitoStat3 in controlling respiration and Ras transformation are mediated by the phosphorylation state of serine 727. To address the role of mitoStat3 in the pathogenesis of cells that are transformed, we used 4T1 breast cancer cells, which form tumors that metastasize in immunocompetent mice. Substitution of Ser-727 for an alanine or aspartate in Stat3 that has a mitochondrial localization sequence, MLS-Stat3, has profound effects on tumor growth, complex I activity of the ETC, and accumulation of reactive oxygen species (ROS). Cells expressing MLS-Stat3(S727A) display slower tumor growth, decreased complex I activity of the ETC, and increased ROS accumulation under hypoxia compared with cells expressing MLS-Stat3. In contrast, cells expressing MLS-Stat3(S727D) show enhanced tumor growth and complex I activity and decreased production of ROS. These results highlight the importance of serine 727 of mitoStat3 in breast cancer and suggest a novel role for mitoStat3 in regulation of ROS concentrations through its action on the ETC.
authors.affiliation: From the Department of Biochemistry and Molecular Biology, and Massey Cancer Center, Virginia Commonwealth University, Richmond, Virginia 23298.
authors.forename: Qifang
authors.initials: Q
authors.lastname: Zhang
authors.forename: Vidisha
authors.initials: V
authors.lastname: Raje
authors.forename: Vasily A
authors.initials: VA
authors.lastname: Yakovlev
authors.forename: Adly
authors.initials: A
authors.lastname: Yacoub
authors.forename: Karol
authors.initials: K
authors.lastname: Szczepanek
authors.forename: Jeremy
authors.initials: J
authors.lastname: Meier
authors.forename: Marta
authors.initials: M
authors.lastname: Derecka
authors.forename: Qun
authors.initials: Q
authors.lastname: Chen
authors.forename: Ying
authors.initials: Y
authors.lastname: Hu
authors.forename: Jennifer
authors.initials: J
authors.lastname: Sisler
authors.forename: Hossein
authors.initials: H
authors.lastname: Hamed
authors.forename: Edward J
authors.initials: EJ
authors.lastname: Lesnefsky
authors.forename: Kristoffer
authors.initials: K
authors.lastname: Valerie
authors.forename: Paul
authors.initials: P
authors.lastname: Dent
authors.forename: Andrew C
authors.initials: AC
authors.lastname: Larner
mesh_terms: D019943:Amino Acid Substitution; D000818:Animals; D002461:Cell Line, Transformed; D045744:Cell Line, Tumor; D042967:Electron Transport Complex I / Q000235:genetics / Q000378:metabolism; D005260:Female; D015674:Mammary Neoplasms, Animal / Q000235:genetics / Q000378:metabolism* / Q000473:pathology; D051379:Mice; D008928:Mitochondria / Q000235:genetics / Q000378:metabolism*; D024101:Mitochondrial Proteins / Q000235:genetics / Q000378:metabolism*; D020125:Mutation, Missense; D009363:Neoplasm Proteins / Q000235:genetics / Q000378:metabolism*; D010766:Phosphorylation / Q000235:genetics; D017382:Reactive Oxygen Species / Q000378:metabolism; D050796:STAT3 Transcription Factor / Q000235:genetics / Q000378:metabolism*; D012694:Serine / Q000235:genetics / Q000378:metabolism
chemical_list: D024101:Mitochondrial Proteins; D009363:Neoplasm Proteins; D017382:Reactive Oxygen Species; D050796:STAT3 Transcription Factor; C494087:Stat3 protein, mouse; D012694:Serine; D042967:Electron Transport Complex I
keywords: Cancer; Mitochondria; Phosphorylation; Reactive Oxygen Species (ROS); STAT3; STAT3 Breast Cancer; Serine
references.citation: Cancer Lett. 2007 Jun 28;251(2):199-210
references.pmid: 17129668
references.citation: Mol Cell Biol. 2001 Nov;21(22):7721-30
references.pmid: 11604508
references.citation: Cell Death Differ. 2007 Feb;14(2):327-37
references.pmid: 16826196
references.citation: Proc Natl Acad Sci U S A. 2005 Jun 7;102(23):8150-5
references.pmid: 15919823
references.citation: Cell. 2007 Feb 9;128(3):589-600
references.pmid: 17289576
references.citation: PLoS One. 2011;6(6):e21680
references.pmid: 21738764
references.citation: Biochemistry. 2007 Oct 23;46(42):11671-83
references.pmid: 17910475
references.citation: Biochemistry. 2010 Jun 29;49(25):5331-9
references.pmid: 20499882
references.citation: Br J Cancer. 2005 May 23;92(10):1892-8
references.pmid: 15841082
references.citation: Cell Res. 2008 Apr;18(4):443-51
references.pmid: 18364677
references.citation: Hum Mol Genet. 2011 Dec 1;20(23):4605-16
references.pmid: 21890492
references.citation: Genes Dev. 2007 Jun 1;21(11):1396-408
references.pmid: 17510282
references.citation: Oncogene. 2003 Feb 13;22(6):894-905
references.pmid: 12584569
references.citation: Circ Res. 2011 Nov 11;109(11):1302-8
references.pmid: 21980124
references.citation: Proc Natl Acad Sci U S A. 2003 Aug 5;100(16):9342-7
references.pmid: 12867595
references.citation: Heart Fail Rev. 2011 Jan;16(1):35-47
references.pmid: 20407820
references.citation: Int J Cancer. 2006 Jun 15;118(12):2943-7
references.pmid: 16425286
references.citation: Curr Protoc Immunol. 2001 May;Chapter 20:Unit 20.2
references.pmid: 18432775
references.citation: Biochem Biophys Res Commun. 2007 Jun 22;358(1):203-8
references.pmid: 17475217
references.citation: PLoS One. 2010 Mar 10;5(3):e9532
references.pmid: 20224768
references.citation: PLoS One. 2013 May 01;8(5):e61532
references.pmid: 23650499
references.citation: Am J Physiol. 1998 Dec;275(6):C1640-52
references.pmid: 9843726
references.citation: Cancer Res. 2005 Apr 1;65(7):2532-6
references.pmid: 15805244
references.citation: J Biol Chem. 2011 Aug 26;286(34):29610-20
references.pmid: 21715323
references.citation: Biochem J. 2002 Dec 1;368(Pt 2):545-53
references.pmid: 12180906
references.citation: Cancers (Basel). 2010 Mar 30;2(2):338-63
references.pmid: 24281073
references.citation: Trends Cell Biol. 2012 Aug;22(8):429-37
references.pmid: 22705015
references.citation: Science. 2009 Feb 6;323(5915):793-7
references.pmid: 19131594
references.citation: Curr Med Chem. 2009;16(10):1266-77
references.pmid: 19355884
references.citation: J Clin Invest. 1997 Dec 15;100(12):3140-8
references.pmid: 9399961
references.citation: Cancer Res. 2010 Oct 15;70(20):8222-32
references.pmid: 20807804
references.citation: Cell. 1993 Sep 24;74(6):1135-45
references.pmid: 8402883
references.citation: Genes Dev. 1995 Apr 15;9(8):984-94
references.pmid: 7774815
references.citation: EMBO J. 2002 Apr 2;21(7):1754-63
references.pmid: 11927559
references.citation: Science. 2009 Jun 26;324(5935):1713-6
references.pmid: 19556508
references.citation: J Exp Med. 2011 Mar 14;208(3):519-33
references.pmid: 21282379
references.citation: Cancer Res. 2008 Oct 1;68(19):7736-41
references.pmid: 18829527
references.citation: Cell Cycle. 2010 Nov 1;9(21):4294-6
references.pmid: 20962592
references.citation: EMBO J. 2003 Mar 17;22(6):1325-35
references.pmid: 12628925
references.citation: Am J Physiol Cell Physiol. 2007 Jan;292(1):C137-47
references.pmid: 16971498